Markova S - Search Results

1

Genotype-dependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation.

Markova S, Nakamura T, Sakaeda T, Makimoto H, Uchiyama H, Okamura N, Okumura K. Markova S, et al. Drug Metab Pharmacokinet. 2006 Jun;21(3):194-200. doi: 10.2133/dmpk.21.194. Drug Metab Pharmacokinet. 2006. PMID: 16858122 Free article.

2

Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells.

Kawakami M, Nakamura T, Okamura N, Komoto C, Markova S, Kobayashi H, Hashimoto N, Okumura K, Sakaeda T. Kawakami M, et al. Among authors: markova s. Biol Pharm Bull. 2007 Jun;30(6):1065-73. doi: 10.1248/bpb.30.1065. Biol Pharm Bull. 2007. PMID: 17541155 Free article.

3

IL-1beta genotype-related effect of prednisolone on IL-1beta production in human peripheral blood mononuclear cells under acute inflammation.

Markova S, Nakamura T, Makimoto H, Ichijima T, Yamamori M, Kuwahara A, Iwaki K, Nishiguchi K, Okamura N, Okumura K, Sakaeda T. Markova S, et al. Biol Pharm Bull. 2007 Aug;30(8):1481-7. doi: 10.1248/bpb.30.1481. Biol Pharm Bull. 2007. PMID: 17666808 Free article.

4

VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese.

Yamamori M, Taniguchi M, Maeda S, Nakamura T, Okamura N, Kuwahara A, Iwaki K, Tamura T, Aoyama N, Markova S, Kasuga M, Okumura K, Sakaeda T. Yamamori M, et al. Among authors: markova s. Int J Med Sci. 2008 Apr 8;5(2):80-6. doi: 10.7150/ijms.5.80. Int J Med Sci. 2008. PMID: 18414651 Free PMC article.

5

Multidrug resistance-associated protein 4 is a determinant of arsenite resistance.

Yuan B, Yoshino Y, Fukushima H, Markova S, Takagi N, Toyoda H, Kroetz DL. Yuan B, et al. Among authors: markova s. Oncol Rep. 2016 Jan;35(1):147-54. doi: 10.3892/or.2015.4343. Epub 2015 Oct 22. Oncol Rep. 2016. PMID: 26497925 Free PMC article.

6

ABCC4 is regulated by microRNA-124a and microRNA-506.

Markova SM, Kroetz DL. Markova SM, et al. Biochem Pharmacol. 2014 Feb 1;87(3):515-22. doi: 10.1016/j.bcp.2013.10.017. Epub 2013 Oct 30. Biochem Pharmacol. 2014. PMID: 24184504 Free PMC article.

7

Response to "CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers".

Markova SM, Schwartz JB, Kroetz DL. Markova SM, et al. Clin Pharmacol Ther. 2014 Mar;95(3):252. doi: 10.1038/clpt.2013.239. Epub 2013 Dec 17. Clin Pharmacol Ther. 2014. PMID: 24346422 No abstract available.

8

Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.

Nguyen TD, Markova S, Liu W, Gow JM, Baldwin RM, Habashian M, Relling MV, Ratain MJ, Kroetz DL. Nguyen TD, et al. Among authors: markova s. Pharmacogenomics J. 2013 Oct;13(5):396-402. doi: 10.1038/tpj.2012.20. Epub 2012 Jun 5. Pharmacogenomics J. 2013. PMID: 22664480 Free PMC article.

9

Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.

Liu Y, Webb HK, Fukushima H, Micheli J, Markova S, Olson JL, Kroetz DL. Liu Y, et al. Among authors: markova s. J Pharmacol Exp Ther. 2012 Jun;341(3):725-34. doi: 10.1124/jpet.111.191247. Epub 2012 Mar 13. J Pharmacol Exp Ther. 2012. PMID: 22414856 Free PMC article.

10

Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping.

Matsson P, Yee SW, Markova S, Morrissey K, Jenkins G, Xuan J, Jorgenson E, Kroetz DL, Giacomini KM. Matsson P, et al. Among authors: markova s. Pharmacogenomics J. 2012 Jun;12(3):214-26. doi: 10.1038/tpj.2011.8. Epub 2011 Mar 8. Pharmacogenomics J. 2012. PMID: 21383772 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page